News Feature

Repeated, human-specific DNA sequences are tied to an increased risk of psychiatric disorders, a Stanford study finds. It might be possible to treat the diseases with existing drugs.

Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.

Prasanna Jagannathan said the $100,000 prize will allow his lab team to ramp up their research in Uganda.

Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.

The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.

More than 700 students, 30 summers, zero tuition: The no-cost Stanford Medical Youth Science Program helps aspiring low-income teens begin their journey toward careers in the medical and health sciences.

Fanconi anemia is a rare but deadly disease thought to be the result of aldehyde-induced DNA damage. Now, Stanford researchers are developing a test that could help kids with the disease and millions more with related conditions.

At Packard Children’s, new surgical and imaging suites will open at the end of June, and the entire second floor of Stanford Hospital, set to open in late 2019, will be devoted to surgery.

Pavilion D will be home to the spine, tumor, and foot and ankle centers; the digestive health and pelvic health centers; and an endoscopy suite.

Noah Hernandez, born in 2017, and James Howell, born in 1955, each benefited from a single liver to treat their life-threatening conditions.